|
|
Avandia - Newsfeeds
-
-
Generic competition for its Valtrex herpes drug and regulatory curbs on sales of the diabetes drug Avandia were also factors. :: The Game Group has announced a sharp drop in pre tax profits for its financial year to the end of January. It has reported a ...
-
-
Excluding the pandemic-flu products, the Valtrex effect, and declining Avandia revenues, overall sales would have grown by 4 percent, Bloomberg notes. Of course, that's a bit like telling people to ignore the elephant in the room. Still, that hidden growth ...
-
-
Lastly, the next bit of information you need to search is the proper treatment for bronchitis which does not include an antibiotic. You should demand the medical provider provide you with a reason that the prescribed treatment will work(with evidence-based ...
-
-
Examples of this abound, such as the recall of Vioxx®, the black box safety warnings for systemic bevacizumab and rosiglitazone (Avandia®), to name some germane instances. Fortunately, in this case, we do have access to a large amount of accumulated data ...
-
-
Examples of this abound, such as the recall of Vioxx®, the black box safety warnings for systemic bevacizumab and rosiglitazone (Avandia®), to name some germane instances. Fortunately, in this case, we do have access to a large amount of accumulated data ...
-
-
The drugs giant said first quarter profits rose 14 per cent to £1.52billion, helped by its £1billion stake sale in blood testing firm Quest Diagnostics and by its offloading of North American rights to cold sore medicine Zovirax. Total sales fell 10 per ...
-
-
Generic competition for its Valtrex herpes drug and regulatory curbs on sales of the diabetes drug Avandia were also factors. :: The Game Group has announced a sharp drop in pre tax profits for its financial year to the end of January. It has reported a ...
-
-
In the fourth quarter of 2010, Glaxo clocked up a rare loss following a £2.2bn legal hit linked to its Avandia drug. Savings from a swingeing costcutting programme and disposals helped to offset a 10% drop in its revenues compared to a year ago.
-
-
The company was hit last year by the EU medicines regulator decision to pull its diabetes product Avandia off the shelves over fears that it increased the risk of heart attack and strokes. Regulators also restricted its availability in the United States.
-
-
Revenue fell 10 percent to 6.6 billion pounds, hit by a fall-off in sales of bird flu vaccine, a big seller a year ago, by generic competition for its Valtrex herpes drug and by regulatory curbs on sales of the diabetes drug Avandia. Excluding those drugs ...
-
-
The British pharmaceutical company saw a steep drop in sales of pandemic flu vaccines and its controversial diabetes drug Avandia. Sales declines in the United States and Europe were offset by gains in emerging markets and Asia. The results met or exceeded ...
-
-
GSK was rocked in September when the EU medicines regulator decided to pull its former diabetes product Avandia off the shelves over fears that it increased the risk of heart attack and strokes. Savings from a major cost-cutting programme and asset ...
-
-
Revenue fell 10 percent, hit by a fall-off in sales of bird flu vaccine, a big seller a year ago, by generic competition for its Valtrex herpes drug and by regulatory curbs on sales of the diabetes drug Avandia. Excluding those drugs, GSK says underlying ...
-
-
MARSHALL — A year to the day after a Gilmer resident died while taking a drug for diabetes, Avandia, family members filed a wrongful death lawsuit against the drug’s manufacturer. James Michael Knight,51, died on April 13, 2009 from a heart attack ...
-
-
How much scientific evidence is there for and against the assertion that exposure to video game violence can harm teens? Three researchers have developed a novel method to consider that question: they analyzed the research output of experts who filed a ...
-
-
Lower Avandia, Valtrex and Advair sales will also have had an impact. However earnings will have got some support from the disposal of the stake in Quest Diagnostics in February.
-
-
More important than the numbers will be confidence shown by management that the company's fortunes have reached a floor -- following the furore over diabetes drug Avandia and big generic hits in 2010 -- and it is now positioned for growth. Dominic Valder ...
-
-
LONDON - Pharmaceutical company GlaxoSmithKline on Wednesday reported a 14 per cent increase in first-quarter net profit, boosted by a gain from selling its remaining stake in Quest Diagnostics. GlaxoSmithKline, maker of Sensodyne toothpaste and Tums ...
-
-
The company said this impact is set to decline going forward and it expects underlying sales growth to translate into sustainable reported growth in 2012. Further, the board declared a first interim dividend of 16 pence per share. The equivalent interim ...
-
-
Exceptional demand for vaccines and anti-flu drug Relenza flattered results a year ago and their absence this year -- plus sharply lower revenue from diabetes pill Avandia and herpes drug Valtrex -- lopped around 1 billion pounds off quarterly sales.
Content provided by MSN. LegalView is not responsible for the accuracy of the information provided above.
Pages:
Previous
1
2
3
4
5
6
7
...
Next
|
|
